About Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation is a rare disease catalogued by Orphanet (ORPHA:289266). It is associated with the GRIN2A gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation trials.
Search ClinicalTrials.gov for "Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation" or filter by Orphanet code ORPHA:289266 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation. Updated daily.